retatrutide gip glp-1 glucagon receptor agonist Retatrutide, a GIP, and agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA Eli Lilly: GLP-1R/GCGR/GIPR Triagonist Reduces
Description
Does it work?

Safety Data Sheet available for laboratory handling and storage information

Learn why peptide stacking is unproven, what the risks are, and which NHS-approved alternatives are available in the UK.

- Reduce avoidable waste

Medical weight loss in Cincinnati with personalized plans, lab testing, and GLP-1 support
